7semiM

Is ASML's earnings report the “canary in the AI mine”?

Equities 10 minutes to read

Summary:  ASML’s Q3 results were better than expected, but disappointing order intake and lower-than-anticipated forecasts for 2025 led to a significant stock drop, raising concerns about potential AI market slowdowns. While ASML still expects growth in the coming years, it will likely be at a slower pace than initially projected, particularly for their advanced EUV chip machines.


Is ASML's earnings report the “canary in the AI mine”?

ASML accidentally released their third-quarter results yesterday afternoon, a day earlier than planned. The result for Q3 was good, and actually slightly better than expected, but the order intake and expectations for next year's revenue and earnings were disappointing, which has sent the stock down by about 20% in less than 24 hours.

ASML’s lower-than-expected expectations for 2025 also dragged down other tech stocks, such as NVIDIA. However, whether this indicates that growth in artificial intelligence is starting to slow down is difficult to say.

On the one hand, ASML itself mentions that growth within artificial intelligence remains high, but on the other hand, they also state that sales of their most advanced chip machines, known as EUV, are slower than initially assumed.

In short, the earnings report could be interpreted to suggest that the AI revolution is moving at full speed, but there are also indications that demand for AI chips in the coming years may be lower than what the market expects today.

If these concerns persist and are confirmed by other tech companies, it could impact the stock prices of all major tech stocks in the near future.

As shown below, sales for the third quarter came out well at 7.5 billion EUR, where the market had expected about 7.2 billion EUR. The big disappointment for Q3, however, is the order intake, which came in at 2.6 billion EUR, whereas ASML was expected to see an order intake of over 5 billion EUR for the quarter.

At the same time, order intake for the quarter within the most advanced EUV machines was only 1.4 billion EUR, which may indicate that demand for the most advanced chips is on the decline, as EUV systems are used to produce the most cutting-edge chips.
2024-10-16-00-ASML-Q3-results
Source: ASML

For Q3 alone, the report is acceptable, and as shown below, ASML delivered 11 new EUV systems in Q3, which is 3 more than in the previous quarter. At the same time, the USA is also beginning to contribute more to revenue, which may indicate that the many initiatives to relocate chip production locally to the US are starting to result in increased American revenue.

2024-10-16-00-ASML-Q3-net-sales
Source: ASML

The big disappointment in ASML’s announcement is not their financial figures or order intake, but their statements regarding 2025.

Before yesterday, the market expected 2025 to be a growth year after a transitional year in 2024, where revenue growth has been close to 0. It was therefore expected that revenue in 2025 would reach around 35 billion EUR, compared to 28 billion EUR in 2024, which represents annual growth of about 25%. However, ASML announced yesterday that they expect revenue of 30-35 billion EUR for next year, and that the expected gross margin for 2025 is 51-53%, whereas the market had previously expected 54%.

The downgrade may not sound dramatic, but given the sky-high expectations for 2025, it is understandable that the stock is hit hard when expectations for 2025 are already being downgraded.

Whether this is a sign of a slowdown in AI growth, and whether this earnings report is the "canary in the AI mine" signaling that it's time to get out, is, as mentioned, difficult to answer, as two different conclusions can be drawn from yesterday's announcement.

The quote from ASML's CFO, Roger Dassen, below, nicely sums up why the report can be interpreted in both directions regarding the development of artificial intelligence.

On the one hand, he mentions that there is still strong development and significant "upside" within the "AI sector", and that it is developments in other microchip markets that are responsible for the lower expectations for 2025 revenue.

On the other hand, he also mentions that it is especially the EUV systems that are experiencing delays due to a change in demand. However, it is precisely EUV systems that are needed to produce, among other things, NVIDIA's next-generation graphics cards or microchips for the latest iPhones. Therefore, this could well indicate that the big tech companies are holding back on buying new machines for chip production due to a potential upcoming slowdown in demand.

"While there continue to be strong developments and upside potential in AI, other market segments are taking longer to recover. It now appears the recovery is more gradual than previously expected. This is expected to continue in 2025, which is leading to customer cautiousness. … leading to several fab push-outs and resulting changes in litho demand timing, in particular EUV."

Although ASML's stock is down over 20% in 24 hours, it is not a catastrophe for the company or the tech sector in general. Yes, it is a big disappointment that sales are not expected to be higher in 2025, as this was expected to be the year when growth truly returned to ASML. As shown below, it was expected, as indicated by the blue line, that revenue would rise to nearly 40 billion EUR by 2026.

Although expectations now need to be adjusted downwards, ASML is still expected to experience decent growth in the coming years, indicated by the orange line.

Yesterday's report was certainly not as good as expected, and possibly this could indicate that overall growth within artificial intelligence is on the decline, but there will still be decent growth in the coming years, even if it may not be as high as initially thought.

2024-10-16-00-ASML-forecasted-growth
Source: Koyfin – figures in billion EUR.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.